Boston Trust Walden Corp Lowers Holdings in Agilent Technologies, Inc. $A

Boston Trust Walden Corp decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 3.0% in the 2nd quarter, Holdings Channel.com reports. The fund owned 187,730 shares of the medical research company’s stock after selling 5,707 shares during the quarter. Boston Trust Walden Corp’s holdings in Agilent Technologies were worth $24,936,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of A. Norges Bank purchased a new position in shares of Agilent Technologies during the 4th quarter worth $549,158,000. AQR Capital Management LLC raised its holdings in Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after buying an additional 1,652,244 shares during the period. Ameriprise Financial Inc. raised its holdings in Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after buying an additional 1,340,161 shares during the period. Balyasny Asset Management L.P. lifted its position in Agilent Technologies by 192.0% in the fourth quarter. Balyasny Asset Management L.P. now owns 1,412,535 shares of the medical research company’s stock valued at $192,204,000 after buying an additional 928,821 shares during the last quarter. Finally, SG Americas Securities LLC lifted its position in Agilent Technologies by 107.2% in the first quarter. SG Americas Securities LLC now owns 1,674,856 shares of the medical research company’s stock valued at $190,900,000 after buying an additional 866,641 shares during the last quarter.

Agilent Technologies Price Performance

Shares of A opened at $149.33 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27. The firm’s 50 day moving average price is $135.12 and its 200 day moving average price is $125.40. The company has a market cap of $42.18 billion, a P/E ratio of 29.99, a PEG ratio of 2.62 and a beta of 1.25. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm’s revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the company posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were issued a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

Analyst Ratings Changes

A has been the subject of a number of recent analyst reports. Piper Sandler assumed coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Barclays increased their price objective on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. Morgan Stanley lifted their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, Robert W. Baird boosted their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.